To say it took a while is an understatement, because #NephJC has been around for 11 years (and still counting)...
π₯ We opened an Instagram account, so if you're around, can follow and interact π£π
#NephSky #Medsky
@elbaonelida.bsky.social
Nephrologist in Mexico, HGM, #NSMC intership 2024 #NephSky #MedSky #LatinSky #HMSky #Kidneydisease #sunrise #NephJC
To say it took a while is an understatement, because #NephJC has been around for 11 years (and still counting)...
π₯ We opened an Instagram account, so if you're around, can follow and interact π£π
#NephSky #Medsky
π£ WCNβ26 Social Media Team Kickoff Meeting
Weβre delighted to welcome our new team members ππΌ
Meet the people behind the content:
π theisn.org/wcn/media/so...
#ISNWCN
π¬ Stay on top of the evidence
At #ISNWCN, the HIT & LBCT sessions spotlight the clinical trials that matter most for patient care, from late-breaking results to ongoing studies.
βAs a community, this helps us stay on top of the evidence base,β says Adeera Levin. Read more: lite.spr.ly/6003OtWX
Meet the #ISNWCN Social Media Team! π A group of health pros bringing you live updates from WCN'26 in Yokohama, π―π΅, with scientific session coverage, quizzes, interviews, visual abstracts, workshops & more! Get ready for engaging content! lite.spr.ly/6008OsHw
12.01.2026 14:31 β π 4 π 2 π¬ 0 π 0#Dapagliflozin in CKD Patients with #Fabry Disease
#VisualAbstract by Elba Medina
https://www.kireports.org/article/S2468-0249(25)00760-0/fulltext
It's 2026!π
We will be counting down the Top Ten Nephrology Stories of 2025 on 1/6/26 at 9 pm EST.
Join us on TWITTER (it will always be Twitter to us).
Come on by #NephJC faithful for a lively discussion! You picked & we're count'em down.
www.nephjc.com/news/2025/1/3/top-stories-in-nephrology-2025
Did we (meaning "you" of course, because you voted) get them right? Is there something missing or is the order wrong? #NephJC #TopTenStories2025
Come discuss with an international cadre of nephrologists & other interested parties on 1/6/26 at 9 pm EST on #Twitter
β¨It's that time of the year again, to nominate the most deserving people in our community for #NephJCKidneys award
πHere's a reminder of previous winners #Nephsky
πYou can nominate worthy individuals/ initiatives by using the hashtag or by using the form
www.nephjc.com/news/2026/1/...
The future of nephrology
18.12.2025 06:34 β π 2 π 3 π¬ 0 π 022/π₯Functional imaging studies have enhanced our understanding of physiology & pathology. πΈ
However, most techniques are limited by variability in platforms, protocols, and image analysis. Standardization is crucial to unlock their full potential!π€³
βNuestras cicatrices nos hacen saber que nuestro pasado fue realβ
Jane Austen
10/ Evaluating tubular function through dynamic physiological stress tests is essential for a comprehensive understanding of kidney function. e.g the furosemide stress test assesses renal tubular integrity.
18.12.2025 04:15 β π 1 π 1 π¬ 1 π 0https://www.kireportscommunity.org/post/towards-new-ways-of-assessing-kidney-function-where-to-look-to-improve
5/ Read the executive summary and watch the meeting video for more information. π₯π₯Start with the majors' key research questionsπ₯π₯
18.12.2025 04:15 β π 1 π 1 π¬ 1 π 0Congratulations to Leo Riella and team reporting physiology aspects from the first porcine kidney transplanted to a human. Happy to have contributed findings on pig renin and the renin-angiotensin system. @natcomms.nature.com @nu-nephrology.bsky.social @nufeinbergmed.bsky.social
rdcu.be/eIyQt
Thanks to @asnpublications.bsky.social for highlighting our feature on a new syndrome of renal tubular alkalosis! www.kidneynews.org/view/journal... @nu-nephrology.bsky.social @nufeinbergmed.bsky.social
16.10.2025 15:28 β π 5 π 3 π¬ 0 π 0Do we continue to measure kidney function with tools from the last century?
The workshop for Kidney Function Assessment of @NIDDKgov proposes a revolution: Go beyond Creatinine & eGFR!
π₯Check out this blog & Skytorial !π§΅π
@kireports.bsky.social
ππππππ
www.kireportscommunity.org/post/towards...
1/Hey #NephTwitter! Welcome to a π #Skytorial brought to you by @kireports.bsky.social @isnkidneycare.bsky.social Our author is @elbaonelida.bsky.social nephrologist at Hospital General de Mexico π²π½ @hgm_nefrologia. Please also check out www.kireportscommunity.org educational #blogposts. FOLLOW US!
18.12.2025 04:15 β π 8 π 2 π¬ 1 π 1The LIBERATE-D VA by
@sejalplakhani.bsky.social
Should we break the pattern of thrice weekly dialysis in AKI-D? #NephJC #NephSky
www.nephjc.com/news/liberateva
Join us for the last #NephJC of 2025, 12/16/25 at 9pm EST!π₯³
How soon should we withhold dialysis in AKI?
We're discussing the LIBERATE-D trial #NephSky
This one might just change your mind π§ π§
Blog by @msocomd.bsky.social and @sejalplakhani.bsky.social
www.nephjc.com/news/liberated-aki
Gracias! @dramiliflores.bsky.social #NephSky
LIBERATE-D: El Resumen Visual β #NephJC
www.nephjc.com/news/2025/12/14/liberate-d-el-resumen-visual
π #NephJCshort by @brianrifkin.bsky.social
RETREAT-FRAIL- pragmatic RCT: is less BP medication worse in octogenarians?
www.nephjc.com/news/hyperte...
Kidney Tertiary #LymphoidTissues and Poor #Immunosuppressive Response in #IgANephropathy #IgAN
#VisualAbstract by Elba Medina
https://www.kireports.org/article/S2468-0249(25)00677-1/fulltext
#NephJCshort on BICAR-ICU2 #Medsky #Nephsky
βοΈ By @nephroseeker.medsky.social
π Bicarbonate makes the picture look cleaner: better pH, more time. But beneath the smoother numbers, the patient hasn't changed. It's the same story, just told in softer colors
www.nephjc.com/news/2025/10...
T3f: #NephJC
Whether dual inhibition APRIL/BAFF offers a longer-term advantage over APRIL-selective therapy remains a key question that only eGFR slope data will answer. APRIL-selective therapy also prevents its action at other receptors (BCMA).
Do you think either has the advantage?
T3d: #NephJC
In VISIONARY, APRIL-selective B-cell inhibition β¬οΈproteinuria & IgA-related biomarkers, confirming APRILβs key pathogenic role.
In ORIGIN-3, ataciceptβs BAFF + APRIL blockade targets earlier B-cell checkpoints, dismantling both the production & maintenance of aberrant IgA response.
T3c: #NephJC
The emerging evidence from APRIL/BAFFβaxis trials (including VISIONARY (sibeprenlimab) & ORIGIN-3 (atacicept)) highlight how central this pathway is to the mechanisms of IgAN.
T2c: #NephJC
1Β° Endpoint
At week 36- ποΈ
πAtacicept: 24-hour urinary protein-to-creatinine ratio decreased by 45.7%
π»Placebo: 24-hour urinary protein-to-creatinine ratio decreased by 6.8%
T0h: #NephJC
Although both BAFF and APRIL are responsible for B-cell proliferation, survival/maturation, and class switching they affect different stages of B cell maturation.
www.kidneynews.org/v...
T0i: #NephJC
Mechanistic lead-in came from the JANUS ph2 study (N=16):
π dose-dependent reductions in IgA, IgG, IgM, and Gd-IgA1 by week 24
πmaintained through week 72
π concurrent proteinuria improvement and preserved eGFR
pubmed.ncbi.nlm.nih....
T0j: #NephJC
The ORIGIN phase 2b trial
π₯ 116 patients with biopsy-proven IgAN and persistent proteinuria despite RASi
π Weekly atacicept 150 mg (wk 36)
β¬οΈ 35% greater UPCR reduction vs placebo
βοΈ a mean eGFR benefit of +5.8 mL/min/1.73 mΒ²
pubmed.ncbi.nlm.nih....